Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease

Identifieur interne : 001B60 ( Istex/Corpus ); précédent : 001B59; suivant : 001B61

Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease

Auteurs : Eng-King Tan ; Yanni Tan ; Anthea Chai ; Christopher Tan ; Hui Shen ; Sau-Ying Lum ; Stephanie M. C. Fook-Cheong ; Mei-Ling Teoh ; Yuan Yih ; Meng-Cheong Wong ; Yi Zhao

Source :

RBID : ISTEX:0C1E01E57BAB424D6CB7054B76BA502BEEF09DB8

English descriptors

Abstract

In a case control study, we examined the association of DRD2 Taq1A and Taq1B polymorphisms and risk of PD, and evaluated the strength of linkage disequilibrium of the polymorphisms. The Taq1A and Taq1B polymorphisms were in strong linkage disequilibrium. There was, however, no significant association of the two polymorphisms with PD. © 2003 Movement Disorder Society

Url:
DOI: 10.1002/mds.10406

Links to Exploration step

ISTEX:0C1E01E57BAB424D6CB7054B76BA502BEEF09DB8

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease</title>
<author>
<name sortKey="Tan, Eng Ing" sort="Tan, Eng Ing" uniqKey="Tan E" first="Eng-King" last="Tan">Eng-King Tan</name>
<affiliation>
<mods:affiliation>Department of Neurology, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>National Neuroscience Institute, SingHealth, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tan, Yanni" sort="Tan, Yanni" uniqKey="Tan Y" first="Yanni" last="Tan">Yanni Tan</name>
<affiliation>
<mods:affiliation>Department of Neurology, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chai, Anthea" sort="Chai, Anthea" uniqKey="Chai A" first="Anthea" last="Chai">Anthea Chai</name>
<affiliation>
<mods:affiliation>Department of Neurology, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tan, Christopher" sort="Tan, Christopher" uniqKey="Tan C" first="Christopher" last="Tan">Christopher Tan</name>
<affiliation>
<mods:affiliation>Department of Neurology, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Shen, Hui" sort="Shen, Hui" uniqKey="Shen H" first="Hui" last="Shen">Hui Shen</name>
<affiliation>
<mods:affiliation>Department of Neurology, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lum, Sau Ing" sort="Lum, Sau Ing" uniqKey="Lum S" first="Sau-Ying" last="Lum">Sau-Ying Lum</name>
<affiliation>
<mods:affiliation>Department of Neurology, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Fook Heong, Stephanie M C" sort="Fook Heong, Stephanie M C" uniqKey="Fook Heong S" first="Stephanie M. C." last="Fook-Cheong">Stephanie M. C. Fook-Cheong</name>
<affiliation>
<mods:affiliation>Department of Clinical Research, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Teoh, Mei Ing" sort="Teoh, Mei Ing" uniqKey="Teoh M" first="Mei-Ling" last="Teoh">Mei-Ling Teoh</name>
<affiliation>
<mods:affiliation>Department of Health Screening, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Yih, Yuan" sort="Yih, Yuan" uniqKey="Yih Y" first="Yuan" last="Yih">Yuan Yih</name>
<affiliation>
<mods:affiliation>Department of Health Screening, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wong, Meng Heong" sort="Wong, Meng Heong" uniqKey="Wong M" first="Meng-Cheong" last="Wong">Meng-Cheong Wong</name>
<affiliation>
<mods:affiliation>Department of Neurology, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zhao, Yi" sort="Zhao, Yi" uniqKey="Zhao Y" first="Yi" last="Zhao">Yi Zhao</name>
<affiliation>
<mods:affiliation>Department of Clinical Research, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0C1E01E57BAB424D6CB7054B76BA502BEEF09DB8</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1002/mds.10406</idno>
<idno type="url">https://api.istex.fr/document/0C1E01E57BAB424D6CB7054B76BA502BEEF09DB8/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001B60</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease</title>
<author>
<name sortKey="Tan, Eng Ing" sort="Tan, Eng Ing" uniqKey="Tan E" first="Eng-King" last="Tan">Eng-King Tan</name>
<affiliation>
<mods:affiliation>Department of Neurology, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>National Neuroscience Institute, SingHealth, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tan, Yanni" sort="Tan, Yanni" uniqKey="Tan Y" first="Yanni" last="Tan">Yanni Tan</name>
<affiliation>
<mods:affiliation>Department of Neurology, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chai, Anthea" sort="Chai, Anthea" uniqKey="Chai A" first="Anthea" last="Chai">Anthea Chai</name>
<affiliation>
<mods:affiliation>Department of Neurology, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tan, Christopher" sort="Tan, Christopher" uniqKey="Tan C" first="Christopher" last="Tan">Christopher Tan</name>
<affiliation>
<mods:affiliation>Department of Neurology, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Shen, Hui" sort="Shen, Hui" uniqKey="Shen H" first="Hui" last="Shen">Hui Shen</name>
<affiliation>
<mods:affiliation>Department of Neurology, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lum, Sau Ing" sort="Lum, Sau Ing" uniqKey="Lum S" first="Sau-Ying" last="Lum">Sau-Ying Lum</name>
<affiliation>
<mods:affiliation>Department of Neurology, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Fook Heong, Stephanie M C" sort="Fook Heong, Stephanie M C" uniqKey="Fook Heong S" first="Stephanie M. C." last="Fook-Cheong">Stephanie M. C. Fook-Cheong</name>
<affiliation>
<mods:affiliation>Department of Clinical Research, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Teoh, Mei Ing" sort="Teoh, Mei Ing" uniqKey="Teoh M" first="Mei-Ling" last="Teoh">Mei-Ling Teoh</name>
<affiliation>
<mods:affiliation>Department of Health Screening, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Yih, Yuan" sort="Yih, Yuan" uniqKey="Yih Y" first="Yuan" last="Yih">Yuan Yih</name>
<affiliation>
<mods:affiliation>Department of Health Screening, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wong, Meng Heong" sort="Wong, Meng Heong" uniqKey="Wong M" first="Meng-Cheong" last="Wong">Meng-Cheong Wong</name>
<affiliation>
<mods:affiliation>Department of Neurology, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zhao, Yi" sort="Zhao, Yi" uniqKey="Zhao Y" first="Yi" last="Zhao">Yi Zhao</name>
<affiliation>
<mods:affiliation>Department of Clinical Research, Singapore General Hospital, Singapore</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2003-05">2003-05</date>
<biblScope unit="vol">18</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="593">593</biblScope>
<biblScope unit="page" to="595">595</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">0C1E01E57BAB424D6CB7054B76BA502BEEF09DB8</idno>
<idno type="DOI">10.1002/mds.10406</idno>
<idno type="ArticleID">MDS10406</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Parkinson's disease</term>
<term>dopamine receptor D2</term>
<term>polymorphism</term>
<term>smoking</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In a case control study, we examined the association of DRD2 Taq1A and Taq1B polymorphisms and risk of PD, and evaluated the strength of linkage disequilibrium of the polymorphisms. The Taq1A and Taq1B polymorphisms were in strong linkage disequilibrium. There was, however, no significant association of the two polymorphisms with PD. © 2003 Movement Disorder Society</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<author>
<json:item>
<name>Eng‐King Tan MD</name>
<affiliations>
<json:string>Department of Neurology, Singapore General Hospital, Singapore</json:string>
<json:string>National Neuroscience Institute, SingHealth, Singapore</json:string>
</affiliations>
</json:item>
<json:item>
<name>Yanni Tan MS</name>
<affiliations>
<json:string>Department of Neurology, Singapore General Hospital, Singapore</json:string>
</affiliations>
</json:item>
<json:item>
<name>Anthea Chai BSc</name>
<affiliations>
<json:string>Department of Neurology, Singapore General Hospital, Singapore</json:string>
</affiliations>
</json:item>
<json:item>
<name>Christopher Tan BSc</name>
<affiliations>
<json:string>Department of Neurology, Singapore General Hospital, Singapore</json:string>
</affiliations>
</json:item>
<json:item>
<name>Hui Shen PhD</name>
<affiliations>
<json:string>Department of Neurology, Singapore General Hospital, Singapore</json:string>
</affiliations>
</json:item>
<json:item>
<name>Sau‐Ying Lum BSc</name>
<affiliations>
<json:string>Department of Neurology, Singapore General Hospital, Singapore</json:string>
</affiliations>
</json:item>
<json:item>
<name>Stephanie M.C. Fook‐Cheong MSc</name>
<affiliations>
<json:string>Department of Clinical Research, Singapore General Hospital, Singapore</json:string>
</affiliations>
</json:item>
<json:item>
<name>Mei‐Ling Teoh MD</name>
<affiliations>
<json:string>Department of Health Screening, Singapore General Hospital, Singapore</json:string>
</affiliations>
</json:item>
<json:item>
<name>Yuan Yih MD</name>
<affiliations>
<json:string>Department of Health Screening, Singapore General Hospital, Singapore</json:string>
</affiliations>
</json:item>
<json:item>
<name>Meng‐Cheong Wong MD</name>
<affiliations>
<json:string>Department of Neurology, Singapore General Hospital, Singapore</json:string>
</affiliations>
</json:item>
<json:item>
<name>Yi Zhao MD, PhD</name>
<affiliations>
<json:string>Department of Clinical Research, Singapore General Hospital, Singapore</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>dopamine receptor D2</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>polymorphism</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>smoking</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Parkinson's disease</value>
</json:item>
</subject>
<language>
<json:string>eng</json:string>
</language>
<abstract>In a case control study, we examined the association of DRD2 Taq1A and Taq1B polymorphisms and risk of PD, and evaluated the strength of linkage disequilibrium of the polymorphisms. The Taq1A and Taq1B polymorphisms were in strong linkage disequilibrium. There was, however, no significant association of the two polymorphisms with PD. © 2003 Movement Disorder Society</abstract>
<qualityIndicators>
<score>5.672</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>612 x 810 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractCharCount>368</abstractCharCount>
<pdfWordCount>5721</pdfWordCount>
<pdfCharCount>37430</pdfCharCount>
<pdfPageCount>9</pdfPageCount>
<abstractWordCount>56</abstractWordCount>
</qualityIndicators>
<title>Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease</title>
<genre>
<json:string>Serial article</json:string>
</genre>
<host>
<volume>18</volume>
<pages>
<total>3</total>
<last>595</last>
<first>593</first>
</pages>
<issn>
<json:string>0885-3185</json:string>
</issn>
<issue>5</issue>
<subject>
<json:item>
<value>Clinical/Scientific Note</value>
</json:item>
</subject>
<genre></genre>
<language>
<json:string>unknown</json:string>
</language>
<title>Movement Disorders</title>
<doi>
<json:string>10.1002/(ISSN)1531-8257</json:string>
</doi>
</host>
<publicationDate>2003</publicationDate>
<copyrightDate>2003</copyrightDate>
<doi>
<json:string>10.1002/mds.10406</json:string>
</doi>
<id>0C1E01E57BAB424D6CB7054B76BA502BEEF09DB8</id>
<fulltext>
<json:item>
<original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/0C1E01E57BAB424D6CB7054B76BA502BEEF09DB8/fulltext/pdf</uri>
</json:item>
<json:item>
<original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/0C1E01E57BAB424D6CB7054B76BA502BEEF09DB8/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/0C1E01E57BAB424D6CB7054B76BA502BEEF09DB8/fulltext/tei">
<teiHeader type="text">
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<availability>
<p>Wiley Subscription Services, Inc., A Wiley Company</p>
</availability>
<date>2003</date>
</publicationStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease</title>
<author>
<persName>
<forename type="first">Eng‐King</forename>
<surname>Tan</surname>
<roleName type="degree">MD</roleName>
</persName>
<note type="correspondence">
<p>Correspondence: Department of Neurology, Singapore General Hospital, Outram Road, 169608 Singapore</p>
</note>
<affiliation>Department of Neurology, Singapore General Hospital, Singapore</affiliation>
<affiliation>National Neuroscience Institute, SingHealth, Singapore</affiliation>
</author>
<author>
<persName>
<forename type="first">Yanni</forename>
<surname>Tan</surname>
<roleName type="degree">MS</roleName>
</persName>
<affiliation>Department of Neurology, Singapore General Hospital, Singapore</affiliation>
</author>
<author>
<persName>
<forename type="first">Anthea</forename>
<surname>Chai</surname>
<roleName type="degree">BSc</roleName>
</persName>
<affiliation>Department of Neurology, Singapore General Hospital, Singapore</affiliation>
</author>
<author>
<persName>
<forename type="first">Christopher</forename>
<surname>Tan</surname>
<roleName type="degree">BSc</roleName>
</persName>
<affiliation>Department of Neurology, Singapore General Hospital, Singapore</affiliation>
</author>
<author>
<persName>
<forename type="first">Hui</forename>
<surname>Shen</surname>
<roleName type="degree">PhD</roleName>
</persName>
<affiliation>Department of Neurology, Singapore General Hospital, Singapore</affiliation>
</author>
<author>
<persName>
<forename type="first">Sau‐Ying</forename>
<surname>Lum</surname>
<roleName type="degree">BSc</roleName>
</persName>
<affiliation>Department of Neurology, Singapore General Hospital, Singapore</affiliation>
</author>
<author>
<persName>
<forename type="first">Stephanie M.C.</forename>
<surname>Fook‐Cheong</surname>
<roleName type="degree">MSc</roleName>
</persName>
<affiliation>Department of Clinical Research, Singapore General Hospital, Singapore</affiliation>
</author>
<author>
<persName>
<forename type="first">Mei‐Ling</forename>
<surname>Teoh</surname>
<roleName type="degree">MD</roleName>
</persName>
<affiliation>Department of Health Screening, Singapore General Hospital, Singapore</affiliation>
</author>
<author>
<persName>
<forename type="first">Yuan</forename>
<surname>Yih</surname>
<roleName type="degree">MD</roleName>
</persName>
<affiliation>Department of Health Screening, Singapore General Hospital, Singapore</affiliation>
</author>
<author>
<persName>
<forename type="first">Meng‐Cheong</forename>
<surname>Wong</surname>
<roleName type="degree">MD</roleName>
</persName>
<affiliation>Department of Neurology, Singapore General Hospital, Singapore</affiliation>
</author>
<author>
<persName>
<forename type="first">Yi</forename>
<surname>Zhao</surname>
<roleName type="degree">MD, PhD</roleName>
</persName>
<affiliation>Department of Clinical Research, Singapore General Hospital, Singapore</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="pISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<idno type="DOI">10.1002/(ISSN)1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2003-05"></date>
<biblScope unit="vol">18</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="593">593</biblScope>
<biblScope unit="page" to="595">595</biblScope>
</imprint>
</monogr>
<idno type="istex">0C1E01E57BAB424D6CB7054B76BA502BEEF09DB8</idno>
<idno type="DOI">10.1002/mds.10406</idno>
<idno type="ArticleID">MDS10406</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2003</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>In a case control study, we examined the association of DRD2 Taq1A and Taq1B polymorphisms and risk of PD, and evaluated the strength of linkage disequilibrium of the polymorphisms. The Taq1A and Taq1B polymorphisms were in strong linkage disequilibrium. There was, however, no significant association of the two polymorphisms with PD. © 2003 Movement Disorder Society</p>
</abstract>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>Keywords</head>
<item>
<term>dopamine receptor D2</term>
</item>
<item>
<term>polymorphism</term>
</item>
<item>
<term>smoking</term>
</item>
<item>
<term>Parkinson's disease</term>
</item>
</list>
</keywords>
</textClass>
<textClass>
<keywords scheme="Journal Subject">
<list>
<head>Article category</head>
<item>
<term>Clinical/Scientific Note</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2002-07-03">Received</change>
<change when="2002-10-18">Registration</change>
<change when="2003-05">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/0C1E01E57BAB424D6CB7054B76BA502BEEF09DB8/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>New York</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8257</doi>
<issn type="print">0885-3185</issn>
<issn type="electronic">1531-8257</issn>
<idGroup>
<id type="product" value="MDS"></id>
</idGroup>
<titleGroup>
<title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title>
<title type="short">Mov. Disord.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="50">
<doi origin="wiley" registered="yes">10.1002/mds.v18:5</doi>
<numberingGroup>
<numbering type="journalVolume" number="18">18</numbering>
<numbering type="journalIssue">5</numbering>
</numberingGroup>
<coverDate startDate="2003-05">May 2003</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="shortCommunication" position="170" status="forIssue">
<doi origin="wiley" registered="yes">10.1002/mds.10406</doi>
<idGroup>
<id type="unit" value="MDS10406"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="3"></count>
</countGroup>
<titleGroup>
<title type="articleCategory">Clinical/Scientific Note</title>
<title type="tocHeading1">Clinical/Scientific Notes</title>
</titleGroup>
<copyright ownership="thirdParty">Copyright © 2003 Movement Disorders Society</copyright>
<eventGroup>
<event type="manuscriptReceived" date="2002-07-03"></event>
<event type="manuscriptRevised" date="2002-10-08"></event>
<event type="manuscriptAccepted" date="2002-10-18"></event>
<event type="firstOnline" date="2003-01-24"></event>
<event type="publishedOnlineFinalForm" date="2003-04-23"></event>
<event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2003-01-24"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.27 mode:FullText source:FullText result:FullText" date="2010-11-22"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst">593</numbering>
<numbering type="pageLast">595</numbering>
</numberingGroup>
<correspondenceTo>Department of Neurology, Singapore General Hospital, Outram Road, 169608 Singapore</correspondenceTo>
<linkGroup>
<link type="toTypesetVersion" href="file:MDS.MDS10406.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<countGroup>
<count type="figureTotal" number="0"></count>
<count type="tableTotal" number="2"></count>
<count type="referenceTotal" number="24"></count>
<count type="wordTotal" number="1937"></count>
</countGroup>
<titleGroup>
<title type="main" xml:lang="en">Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease</title>
<title type="short" xml:lang="en">Clinical/Scientific Notes</title>
</titleGroup>
<creators>
<creator xml:id="au1" creatorRole="author" affiliationRef="#af1 #af4" corresponding="yes">
<personName>
<givenNames>Eng‐King</givenNames>
<familyName>Tan</familyName>
<degrees>MD</degrees>
</personName>
<contactDetails>
<email>gnrtek@sgh.com.sg</email>
</contactDetails>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>Yanni</givenNames>
<familyName>Tan</familyName>
<degrees>MS</degrees>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>Anthea</givenNames>
<familyName>Chai</familyName>
<degrees>BSc</degrees>
</personName>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>Christopher</givenNames>
<familyName>Tan</familyName>
<degrees>BSc</degrees>
</personName>
</creator>
<creator xml:id="au5" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>Hui</givenNames>
<familyName>Shen</familyName>
<degrees>PhD</degrees>
</personName>
</creator>
<creator xml:id="au6" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>Sau‐Ying</givenNames>
<familyName>Lum</familyName>
<degrees>BSc</degrees>
</personName>
</creator>
<creator xml:id="au7" creatorRole="author" affiliationRef="#af2">
<personName>
<givenNames>Stephanie M.C.</givenNames>
<familyName>Fook‐Cheong</familyName>
<degrees>MSc</degrees>
</personName>
</creator>
<creator xml:id="au8" creatorRole="author" affiliationRef="#af3">
<personName>
<givenNames>Mei‐Ling</givenNames>
<familyName>Teoh</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au9" creatorRole="author" affiliationRef="#af3">
<personName>
<givenNames>Yuan</givenNames>
<familyName>Yih</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au10" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>Meng‐Cheong</givenNames>
<familyName>Wong</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au11" creatorRole="author" affiliationRef="#af2">
<personName>
<givenNames>Yi</givenNames>
<familyName>Zhao</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="af1" countryCode="SG" type="organization">
<unparsedAffiliation>Department of Neurology, Singapore General Hospital, Singapore</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="SG" type="organization">
<unparsedAffiliation>Department of Clinical Research, Singapore General Hospital, Singapore</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af3" countryCode="SG" type="organization">
<unparsedAffiliation>Department of Health Screening, Singapore General Hospital, Singapore</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af4" countryCode="SG" type="organization">
<unparsedAffiliation>National Neuroscience Institute, SingHealth, Singapore</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en" type="author">
<keyword xml:id="kwd1">dopamine receptor D2</keyword>
<keyword xml:id="kwd2">polymorphism</keyword>
<keyword xml:id="kwd3">smoking</keyword>
<keyword xml:id="kwd4">Parkinson's disease</keyword>
</keywordGroup>
<abstractGroup>
<abstract type="main" xml:lang="en">
<title type="main">Abstract</title>
<p>In a case control study, we examined the association of DRD2 Taq1A and Taq1B polymorphisms and risk of PD, and evaluated the strength of linkage disequilibrium of the polymorphisms. The Taq1A and Taq1B polymorphisms were in strong linkage disequilibrium. There was, however, no significant association of the two polymorphisms with PD. © 2003 Movement Disorder Society</p>
</abstract>
</abstractGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<!--Version 0.6 générée le 4-12-2015-->
<mods version="3.6">
<titleInfo lang="en">
<title>Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>Clinical/Scientific Notes</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease</title>
</titleInfo>
<name type="personal">
<namePart type="given">Eng‐King</namePart>
<namePart type="family">Tan</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, Singapore General Hospital, Singapore</affiliation>
<affiliation>National Neuroscience Institute, SingHealth, Singapore</affiliation>
<description>Correspondence: Department of Neurology, Singapore General Hospital, Outram Road, 169608 Singapore</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Yanni</namePart>
<namePart type="family">Tan</namePart>
<namePart type="termsOfAddress">MS</namePart>
<affiliation>Department of Neurology, Singapore General Hospital, Singapore</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Anthea</namePart>
<namePart type="family">Chai</namePart>
<namePart type="termsOfAddress">BSc</namePart>
<affiliation>Department of Neurology, Singapore General Hospital, Singapore</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Christopher</namePart>
<namePart type="family">Tan</namePart>
<namePart type="termsOfAddress">BSc</namePart>
<affiliation>Department of Neurology, Singapore General Hospital, Singapore</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Hui</namePart>
<namePart type="family">Shen</namePart>
<namePart type="termsOfAddress">PhD</namePart>
<affiliation>Department of Neurology, Singapore General Hospital, Singapore</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Sau‐Ying</namePart>
<namePart type="family">Lum</namePart>
<namePart type="termsOfAddress">BSc</namePart>
<affiliation>Department of Neurology, Singapore General Hospital, Singapore</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Stephanie M.C.</namePart>
<namePart type="family">Fook‐Cheong</namePart>
<namePart type="termsOfAddress">MSc</namePart>
<affiliation>Department of Clinical Research, Singapore General Hospital, Singapore</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Mei‐Ling</namePart>
<namePart type="family">Teoh</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Health Screening, Singapore General Hospital, Singapore</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Yuan</namePart>
<namePart type="family">Yih</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Health Screening, Singapore General Hospital, Singapore</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Meng‐Cheong</namePart>
<namePart type="family">Wong</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, Singapore General Hospital, Singapore</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Yi</namePart>
<namePart type="family">Zhao</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>Department of Clinical Research, Singapore General Hospital, Singapore</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="originalCategForm">shortCommunication</genre>
<originInfo>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place>
<placeTerm type="text">New York</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2003-05</dateIssued>
<dateCaptured encoding="w3cdtf">2002-07-03</dateCaptured>
<dateValid encoding="w3cdtf">2002-10-18</dateValid>
<copyrightDate encoding="w3cdtf">2003</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
<extent unit="tables">2</extent>
<extent unit="references">24</extent>
<extent unit="words">1937</extent>
</physicalDescription>
<abstract lang="en">In a case control study, we examined the association of DRD2 Taq1A and Taq1B polymorphisms and risk of PD, and evaluated the strength of linkage disequilibrium of the polymorphisms. The Taq1A and Taq1B polymorphisms were in strong linkage disequilibrium. There was, however, no significant association of the two polymorphisms with PD. © 2003 Movement Disorder Society</abstract>
<subject lang="en">
<genre>Keywords</genre>
<topic>dopamine receptor D2</topic>
<topic>polymorphism</topic>
<topic>smoking</topic>
<topic>Parkinson's disease</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Movement Disorders</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>Mov. Disord.</title>
</titleInfo>
<subject>
<genre>article category</genre>
<topic>Clinical/Scientific Note</topic>
</subject>
<identifier type="ISSN">0885-3185</identifier>
<identifier type="eISSN">1531-8257</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8257</identifier>
<identifier type="PublisherID">MDS</identifier>
<part>
<date>2003</date>
<detail type="volume">
<caption>vol.</caption>
<number>18</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>5</number>
</detail>
<extent unit="pages">
<start>593</start>
<end>595</end>
<total>3</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">0C1E01E57BAB424D6CB7054B76BA502BEEF09DB8</identifier>
<identifier type="DOI">10.1002/mds.10406</identifier>
<identifier type="ArticleID">MDS10406</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2003 Movement Disorders Society</accessCondition>
<recordInfo>
<recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
<recordContentSource>WILEY</recordContentSource>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B60 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001B60 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:0C1E01E57BAB424D6CB7054B76BA502BEEF09DB8
   |texte=   Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024